Preprint Article Version 1 This version is not peer-reviewed

Use of Intravascular Micro-Axial Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock: Mid-Term Outcomes

Version 1 : Received: 15 October 2024 / Approved: 16 October 2024 / Online: 16 October 2024 (10:15:46 CEST)

How to cite: Mahesh, B.; Peddayyavarla, P.; Nguyen, K.; Mahesh, A.; Hartford, C.; Devich, R.; Dafflisio, G.; Nair, N.; Fruendt, M.; Dowling, R.; Soleimani, B. Use of Intravascular Micro-Axial Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock: Mid-Term Outcomes. Preprints 2024, 2024101254. https://doi.org/10.20944/preprints202410.1254.v1 Mahesh, B.; Peddayyavarla, P.; Nguyen, K.; Mahesh, A.; Hartford, C.; Devich, R.; Dafflisio, G.; Nair, N.; Fruendt, M.; Dowling, R.; Soleimani, B. Use of Intravascular Micro-Axial Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock: Mid-Term Outcomes. Preprints 2024, 2024101254. https://doi.org/10.20944/preprints202410.1254.v1

Abstract

Objectives: Cardiogenic shock [CS] is associated with a high-mortality. Suitable patients maybe successfully bridged using newer intravascular micro-axial left-ventricular assist devices [M-LVAD] for recovery or determination of definitive therapy. Methods: Between January-2020 and July-2024, 107 patients underwent placement of M-LVAD for CS. The cohort was divided into 4 groups based on their destination; group-1: 34 patients [32%] receiving transplant; group-2: 25 patients [23%] receiving durable LVAD; group-3: 42 patients [39%] bridging from post-cardiotomy CS [PCCS]; and group-4: 6 patients [5.6%] bridging decision/recovery [these were excluded from analysis]. Multivariable logistic-regression [MLR] and Cox-regression [MCR] models identified predictors of early-hospital and late mortality, with data reported as odds ratios [ORs], and hazard ratios [HRs], respectively. P

Keywords

ECMO; cardiogenic shock; micro-axial left ventricular assist device; temporary mechanical circulatory support; heart recovery; heart replacement

Subject

Medicine and Pharmacology, Cardiac and Cardiovascular Systems

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.